식물-미생물 상호작용 연구 위한 실험실 생태계의 건설에 대 한 생태계 제조 (EcoFAB) 프로토콜

Executive Industry Relevance

EcoFABs provide a standardized, reproducible platform for mechanistic studies of plant-microbe interactions under controlled laboratory conditions. This enables de-risking of target validation in agricultural biotechnology by clarifying functional roles of microbiomes in plant health and stress response. The system supports predictive confidence in lead identification for microbiome-based bioinputs through dynamic monitoring of root exudates, microbial localization, and plant growth phenotypes.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of therapeutic hypotheses by manipulating microbiome composition, including mutant strains, to assess causal effects on plant phenotypes.
• Operational Value: Supports functional target validation through controlled addition of plant growth promoting rhizobacteria such as Pseudomonas simiae WCS417 and quantification of colonization patterns.
• Predictive Value: Facilitates mechanistic de-risking by linking microbial interventions to measurable outputs like root morphology, exudate composition, and growth kinetics.

Screening & Assay Development

• Assay Readiness: Prepares validated biological systems for downstream workflows by enabling sterile, reproducible mounting of seedlings and controlled media exchange in flow-through devices.
• Quantitative Outputs: Generates standardized metrics including total root area over time, microbial localization via mass spectrometry imaging, and exudate profiling for compound screening.
• Platform Reuse: Designed for scalability across plant species (Arabidopsis, Brachypodium, Panicum) and growth media (hydroponic, sand, soil), supporting cross-project standardization.

Translational & Preclinical Research

• Disease Relevance: Models plant-soil-microbe interactions relevant to sustainable agriculture and bioenergy feedstock production.
• Translational Continuity: Bridges discovery through preclinical validation by allowing progression from sterile lab conditions to defined soil/sand systems with supplemental media.
• Risk-Adjusted Advancement: Enables go/no-go decisions based on reproducible phenotypes under controlled stress or nutrient conditions prior to field testing.

Pipeline & Workflow Integration

EcoFABs integrate into the discovery continuum from hypothesis testing in early discovery to lead identification and preclinical validation, supporting iterative design-test cycles for microbiome-based agricultural solutions.

• Discovery Biology: Supports hypothesis testing and pathway clarification by enabling manipulation of microbiome composition and environmental variables while monitoring plant responses.
• Screening: Delivers assay readiness and reproducibility through sterile fabrication, controlled hydration, and sealed incubation systems that minimize evaporation and contamination.
• Analytics: Provides quantitative measurements including root morphology imaging, metabolite profiling, and mass spectrometry data to compare experimental conditions.
• Translational Research: Connects to preclinical continuity by supporting validation in increasingly complex media (sand, soil) while maintaining controlled variables.
• Enterprise Reuse: Designed as a reusable platform rather than a single-use tool, with modular design allowing adaptation across labs and plant models.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity in plant-microbe interactions.
• Operational Value: Ensures standardization and reproducibility through detailed sterilization protocols, 3D-printed molds, and controlled environmental conditions.
• Strategic Value: Improves go/no-go decisions and capital efficiency by enabling early de-risking of microbiome-based leads before field trials.
• Portfolio Impact: Supports risk-adjusted prioritization through quantitative, reproducible phenotypes linked to microbial interventions.

Implementation Considerations

• Requires expertise in sterile technique, 3D printing, and PDMS handling for device fabrication.
• Depends on access to plasma cleaners, vacuum chambers, and imaging systems for bonding and analysis.
• Necessitates cross-team standardization of protocols for seed transfer, media exchange, and contamination control.
• Requires adaptation considerations when switching between liquid, sand, or soil-based growth media while maintaining sterility.
• Limited by the need for aseptic workflows during exudate sampling and media refresh to prevent biofilm formation.

Biopharma FAQs